High‐Dose Cyclophosphamide in the Treatment of Multiple Sclerosis

High dose cyclophosphamide (HDC) has been successfully used for the treatment of a variety of autoimmune diseases. In this study, we sought to determine whether the use of high dose cyclophosphamide provided stabilization of relapsing remitting MS (RRMS), secondary progressive MS (SPMS), or primary...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:CNS Neurosci Ther
Prif Awduron: Schwartzman, Robert Jay, Simpkins, Nicole, Alexander, Guillermo M., Reichenberger, Erin, Ward, Kristine, Lindenberg, Noah, Topolsky, David, Crilley, Pam
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Blackwell Publishing Ltd 2009
Pynciau:
Drug Focus
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6494060/
https://ncbi.nlm.nih.gov/pubmed/19243391
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1755-5949.2008.00072.x
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg